Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Eur J Immunol ; 31(8): 2487-96, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11500833

ABSTRACT

Th1 and Th2 cells produce different cytokines and have distinct functions. Th1/Th2 cell differentiation is influenced, among other factors, by the nature of TCR-MHC interactions. However, how the TCR transduces a signal resulting in IFN-gamma or IL-4 production is a matter of debate. For example, some authors reported a loss of calcium signaling pathway in Th2 cells. We used a T cell hybridoma producing IL-4 upon weak TCR stimulation and both IL-4 and IFN-gamma for strong TCR engagement as a model to study how TCR signaling pathways are differentially activated in both conditions of stimulation and how this influences the production of cytokines. We show that: (1) the calcium response is identical following weak and strong TCR stimulation; (2) mitogen-activated protein kinase(MAPK) activation is a gradual phenomenon depending upon the strength of TCR activation; (3) a calcium response, even weak, triggers IL-4 expression; (4) IFN-gamma synthesis requires not only a calcium response but also MAPK activation. The MAPK pathway is dispensable for IL-4 production, although it amplifies IL-4 synthesis upon strong TCR stimulation; (5) TCR-induced IL-4 production also depends on calcium signaling in Th2 cells, while IFN-gamma synthesis is dependent, in addition, on MAPK activation in Th1 cells.


Subject(s)
Calcium Signaling , Chemokines, CC , Interferon-gamma/biosynthesis , Interleukin-4/biosynthesis , MAP Kinase Signaling System , Receptors, Antigen, T-Cell/metabolism , T-Lymphocytes/metabolism , Animals , Blotting, Western , Calcium/metabolism , Calcium Signaling/drug effects , Cell Line , Chemokine CCL11 , Cytokines/pharmacology , Enzyme Activation/drug effects , Gene Expression Regulation/drug effects , Hybridomas/drug effects , Hybridomas/metabolism , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-4/genetics , Interleukin-4/immunology , MAP Kinase Signaling System/drug effects , Mice , Mice, Inbred BALB C , Mitogen-Activated Protein Kinases/metabolism , Phosphorylation/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/enzymology , T-Lymphocytes/immunology , Tetradecanoylphorbol Acetate/pharmacology , Th1 Cells/drug effects , Th1 Cells/enzymology , Th1 Cells/immunology , Th1 Cells/metabolism , Th2 Cells/drug effects , Th2 Cells/enzymology , Th2 Cells/immunology , Th2 Cells/metabolism , Thapsigargin/pharmacology
2.
Eur J Immunol ; 31(8): 2266-76, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11477538

ABSTRACT

Gold salts are beneficial in the treatment of rheumatoid arthritis but may induce immune-mediated disorders in predisposed patients. Gold salts induce Th2-dependent autoimmunity in Brown-Norway (BN) rats but not in Lewis (LEW) rats. The aim of this study was to define molecular targets of gold salts and to approach why LEW rats are resistant. Gold salts act on early steps of transduction in T cells from BN and LEW rats since they trigger tyrosine phosphorylation of numerous proteins including p56(lck) and a calcium signal which results in IL-4 and IFN-gamma expression by BN and LEW T cells. However, the IL-4 response was favored in BN spleen cells in vitro and in vivo. IFN-gamma, produced in part by CD8(+) cells, contributes to the resistance of LEW rats since gold salt-injected LEW rats receiving anti-CD8 or anti-IFN-gamma mAb displayed the parameters characteristics of gold salt-induced Th2 autoimmunity although to a lesser extent than in BN rats. Gold salts transduce a signal in BN and LEW spleen cells resulting in IL-4 and IFN-gamma gene transcription with a preferential IL-4 response in BN rats, a Th2-prone strain, while IFN-gamma contributes to the resistance of LEW rats.


Subject(s)
Autoimmunity/immunology , Chlorides/pharmacology , Gene Expression Regulation/drug effects , Gold Compounds/pharmacology , Gold/pharmacology , Interleukin-4/biosynthesis , Lymphocyte Activation/drug effects , T-Lymphocytes/drug effects , Animals , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Autoimmunity/drug effects , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Calcium/metabolism , Calcium Signaling/drug effects , Immunoglobulin E/immunology , Immunoglobulin G/immunology , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-4/genetics , Interleukin-4/immunology , Phosphorylation/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Inbred BN , Rats, Inbred Lew , Spleen/cytology , Spleen/drug effects , Spleen/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Th2 Cells/drug effects , Th2 Cells/immunology , Th2 Cells/metabolism
4.
Curr Protoc Immunol ; Chapter 15: Unit 15.15, 2001 May.
Article in English | MEDLINE | ID: mdl-18432732

ABSTRACT

This unit describes methods for inducing autoimmune disease in Brown Norway rats through HgCl(2) injections as well for assessing parameters that characterize the disease by serum IgE concentration assays, anti-laminin antibody measurement, and renal immunofluorescence studies to detect autoantibodies. Also covered are disease induction using autoreactive CD4(+) T(H)2 anti-self MHC class II molecules and preparation of T cell lines. IL-4 is produced very early after the first HgCl(2) injection (beginning at day 3, peaking at day 14, and continuing up to day 30). Thus, IL-4 mRNA expression may be detected in spleen and lymph nodes from HgCl(2)-injected BN rats. The fact that HgCl(2) induces in vitro mRNA IL-4 gene expression in normal BN T cells but not in LEW T cells is probably crucial to susceptibility to the development of autoimmunity in the sense that it may condition the development of autoreactive T cells into pathogenic T(H)2 cells; a test for this condition is therefore also included.


Subject(s)
Autoimmune Diseases/chemically induced , Autoimmune Diseases/immunology , Disease Models, Animal , Mercuric Chloride , Animals , Female , Gene Expression Regulation/genetics , Gene Expression Regulation/immunology , Interleukin-4/biosynthesis , Interleukin-4/genetics , Interleukin-4/immunology , Male , RNA, Messenger/genetics , Rats , Rats, Inbred BN , T-Lymphocytes/immunology , Th2 Cells/immunology
5.
J Soc Biol ; 195(3): 319-26, 2001.
Article in French | MEDLINE | ID: mdl-11833470

ABSTRACT

In asymptomatic patients infected by HIV-1, the level of IL-10, a cytokine with immunosuppressive activity, is associated with the course of HIV infection towards AIDS. We show that HIV-1 Tat, a viral protein secreted by infected cells, induces IL-10 production by human peripheral blood monocytes. The analysis of the signal transduction pathways strongly suggests that the protein kinase C may play an essential role in this induction. Stimulation by Tat induces nuclear translocation of the transcription factor NFkB the activation of which seems to be necessary for IL-10 production. Using microspectrofluorimetry and confocal microscopy, we also show that Tat induces a calcium influx.


Subject(s)
Calcium/metabolism , Gene Products, tat/pharmacology , Interleukin-10/biosynthesis , Monocytes/metabolism , Protein Kinase C/metabolism , HIV-1 , Humans , NF-kappa B/physiology , tat Gene Products, Human Immunodeficiency Virus
6.
J Virol ; 74(22): 10551-62, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11044099

ABSTRACT

The clinical manifestations observed in human immunodeficiency virus type 1 (HIV-1)-infected patients are primarily due to the capacity of the virus and its components to inactivate the immune system. HIV-1 Tat protein could participate in this immune system disorder. This protein is secreted by infected cells of HIV-infected patients and is free in the plasma, where it can interact and be taken up by both infected and noninfected cells. In asymptomatic patients infected by HIV-1, production of interleukin-10 (IL-10), a highly immunosuppressive cytokine, is associated with disease progression to AIDS. In the present work, we tested the capacity of Tat to induce IL-10 production by peripheral blood monocytes of healthy donors. The results show that Tat causes the production of IL-10 in a dose- and stimulation time-dependent manner. Investigations of the mechanisms involved in signal transduction show that (i) the calcium pathway is not or only slightly involved in Tat-induced IL-10 production, (ii) the protein kinase C pathway plays an essential role, and (iii) monocyte stimulation by Tat results in the intranuclear translocation of transcription factor NF-kappaB and in the induction of phosphorylation of the mitogen-activated protein kinases ERK1 and ERK2; activation of these two potential substrates of protein kinase C is required for the production of IL-10. Finally, our results suggest that the effect of Tat is exerted at the membrane level and that the active domain is located within N-terminal residues 1 to 45. This production of IL-10 induced by Tat could participate in the progression of HIV infection to AIDS.


Subject(s)
Gene Products, tat/immunology , HIV-1/metabolism , Interleukin-10/biosynthesis , Monocytes/immunology , Protein Kinase C/metabolism , Calcium/metabolism , Gene Products, tat/genetics , Humans , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/metabolism , Monocytes/metabolism , NF-kappa B/metabolism , Signal Transduction , tat Gene Products, Human Immunodeficiency Virus
7.
J Exp Med ; 185(10): 1769-75, 1997 May 19.
Article in English | MEDLINE | ID: mdl-9151702

ABSTRACT

Autoreactive anti-MHC class II T cells are found in Brown Norway (BN) and Lewis (LEW) rats that receive either HgCl2 or gold salts. These T cells have a T helper cell 2 (Th2) phenotype in the former strain and are responsible for Th2-mediated autoimmunity. In contrast, T cells that expand in LEW rats produce IL-2 and prevent experimental autoimmune encephalomyelitis, a cell-mediated autoimmune disease. The aim of this work was to investigate, using T cell lines derived from HgCl2-injected LEW rats (LEWHg), the effect of these autoreactive T cells on the development of Th2-mediated autoimmunity. The five LEWHg T cell lines obtained protect against Th2-mediated autoimmunity induced by HgCl2 in (LEW x BN)F1 hybrids. The lines produce, in addition to IL-2, IFN-gamma and TGF-beta, and the protective effect is TGF-beta dependent since protection is abrogated by anti-TGF-beta treatment. These results identify regulatory, TGF-beta-producing, autoreactive T cells that are distinct from classical Th1 or Th2 and inhibit both Th1- and Th2-mediated autoimmune diseases.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Encephalomyelitis, Autoimmune, Experimental/immunology , Histocompatibility Antigens Class II/immunology , T-Lymphocytes/immunology , Th2 Cells/immunology , Transforming Growth Factor beta/physiology , Adoptive Transfer , Animals , Antibodies, Monoclonal , Antibody Formation , Autoimmunity , Immunoglobulin E/blood , Interferon-gamma/biosynthesis , Interleukin-2/biosynthesis , Major Histocompatibility Complex , Mercury Poisoning/immunology , Rats , Rats, Inbred BN , Rats, Inbred Lew , Th1 Cells/immunology , Th2 Cells/drug effects , Thymectomy , Transforming Growth Factor beta/biosynthesis , Transforming Growth Factor beta/immunology
8.
J Biol Chem ; 272(51): 32411-8, 1997 Dec 19.
Article in English | MEDLINE | ID: mdl-9405450

ABSTRACT

Mercuric chloride (HgCl2) induces T helper 2 (Th2) autoreactive anti-class II T cells in Brown Norway rats. These cells produce interleukin (IL)-4 and induce a B cell polyclonal activation that is responsible for autoimmune disease. In Brown Norway rats, HgCl2 triggers early IL-4 mRNA expression both in vivo and in vitro by T cells, which may explain why autoreactive anti-class II T cells acquire a Th2 phenotype. The aim of this study was to explore the transduction pathways by which this chemical operates. By using two murine T cell hybridomas that express IL-4 mRNA upon stimulation with HgCl2, we demonstrate that: 1) HgCl2 acts at the transcriptional level without requiring de novo protein synthesis; 2) HgCl2 induces a protein kinase C-dependent Ca2+ influx through L-type calcium channels; 3) calcium/calcineurin-dependent pathway and protein kinase C activation are both implicated in HgCl2-induced IL-4 gene expression; and 4) HgCl2 can activate directly protein kinase C, which might be one of the main intracellular target for HgCl2. These data are in agreement with an effect of HgCl2 which is independent of antigen-specific recognition. It may explain the T cell polyclonal activation in the mercury model and the expansion of pathogenic autoreactive anti-class II Th2 cells in this context.


Subject(s)
Calcium Channels/metabolism , Calcium/metabolism , Gene Expression Regulation/drug effects , Interleukin-4/genetics , Mercuric Chloride/pharmacology , Protein Kinase C/metabolism , T-Lymphocytes/metabolism , Animals , Cell-Free System , Enzyme Activation , Hybridomas , Ion Transport , RNA, Messenger/genetics , Rats
9.
Am J Physiol ; 269(1 Pt 2): F103-9, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7631823

ABSTRACT

Adenosine 3',5'-cyclic monophosphate (cAMP), accumulated in the presence of adenosine, was measured in medullary portions of mouse thick ascending limbs of Henle's loop, suspended either in classic extracellular buffer or in the presence of added NaCl. Under control conditions (140 mmol/l NaCl), adenosine (< 10(-5) mol/l) and N6-cyclohexyladenosine, an A1 adenosine receptor agonist, inhibit the cAMP accumulation induced by arginine vasopressin (AVP). On the other hand, high concentrations of adenosine and CGS-21680, an A2 adenosine receptor agonist, stimulate cAMP formation. Addition of NaCl (+300 mmol/l) to extracellular buffer stimulates the release of endogenous adenosine. It also enhances A2 receptor-induced cAMP accumulation but suppresses A1 receptor-mediated inhibition of adenylyl cyclase. This hypertonic NaCl medium also potentiates the stimulatory action of AVP on adenylyl cyclase. The modifications of tubular responses to both AVP and A1 and A2 agonists, brought about by hypertonic NaCl, were all inhibited by adenosine deaminase, thereby demonstrating the involvement of endogenous adenosine. Adenosine, the release and the effects of which are modulated by hypertonic NaCl, thus appears to act as an endogenous physiological modulator of kidney medulla function.


Subject(s)
Adenosine/metabolism , Cyclic AMP/biosynthesis , Hormones/physiology , Loop of Henle/metabolism , Saline Solution, Hypertonic/pharmacology , Adenosine/pharmacology , Animals , Arginine Vasopressin/pharmacology , Male , Mice , Mice, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...